Get the Stockscreener App
5.21
2.44%
-0.1305
Radiopharm Theranostics Ltd Adr stock is traded at $5.21, with a volume of 45,703.
It is down -2.44% in the last 24 hours and up +18.68% over the past month.
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
See More
Previous Close:
$5.3405
Open:
$5.5
24h Volume:
45,703
Relative Volume:
1.04
Market Cap:
$11.47B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.52%
1M Performance:
+18.68%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.86
$5.50
1-Week Range:
$4.55
$5.88
52-Week Range:
$3.5501
$50.82
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
Name
Radiopharm Theranostics Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare RADX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RADX
Radiopharm Theranostics Ltd Adr
|
5.21 | 11.47B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Radiopharm Theranostics Ltd Adr Stock (RADX) Latest News
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga
Radiopharm completes preclinical tests for cancer drug RAD 402 - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com UK
Radiopharm Achieves Nasdaq Listing of American Depositary Shares - GlobeNewswire
Radiopharm Theranostics Set for Nasdaq Debut Under RADX Symbol | RADX Stock News - StockTitan
Radiopharm Theranostics Reports Promising Study Results - MSN
Radiopharm Theranostics (ASX:RAD) Advances Cancer Trials and Expands US Presence - Kalkine Media
Radiopharm Theranostics Marks Progress and Expands US Access - TipRanks
Radiopharm Theranostics launching American Depositary Receipt program - Biotech Dispatch
DBDeutsche Bank Aktiengesellschaft Latest Stock News & Market Updates - StockTitan
Market Data Center - Barron's
U.S. STOCKS - The Wall Street Journal
Radiopharm Theranostics Ltd Adr Stock (RADX) Financials Data
There is no financial data for Radiopharm Theranostics Ltd Adr (RADX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):